Covered recipient · General Payments record
NATHALIE STEENERSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$427.32
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $427.32 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $238.89 | 4 |
| Neurocrine BioSciences, Inc. | $113.64 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $32.95 | 2 |
| Astellas Pharma US Inc | $20.95 | 1 |
| Lilly USA, LLC | $20.89 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $427.32 | 9 |
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $20.95 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139522380 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $19.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146790813 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.69 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146793576 | CMS |
| Lilly USA, LLC | $20.89 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135897012 | CMS |
| Neurocrine Biosciences, Inc. | $113.64 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150924176 | CMS |
| Novo Nordisk Inc | $99.61 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100366237 | CMS |
| Novo Nordisk Inc | $19.80 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100334650 | CMS |
| Novo Nordisk Inc | $6.96 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100346376 | CMS |
| Novo Nordisk Inc | $112.52 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100319622 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.